Trial Information

Summary: Sexual Dysfunction

Menopause ... has it changed your sex life?

Many women notice a change in their sexual health upon passing through menopause or after having a hysterectomy. If you're a woman experiencing a recurrent or persistent change in sexual function, you may qualify for a research study of an investigational medication for women who are 48 yrs. or older.

If you have not used hormone replacement therapy in the last 6 months and are 3 years postmenopausal, experiencing decreased sexual arousal or decreased desire for sexual activity, you may qualify.

All qualified participants will receive study-related medical exam, study medication as well as compensation for participation. Your inquiry will be kept confidential.

Contact Rapid Medical Research to see how to participate.

Contact:

Rapid Medical Research, Inc. (RMR)
3619 Park East Drive, Suite 109
Cleveland, OH 44122
Telephone: 216-682-0320 or Toll-free 888-460-2275
Fax: 216-682-0326
Email:

Profile Page: Rapid Medical Research, Inc. (RMR), Cleveland, OH

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:27 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA